Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imidazopyrazines as cyclin dependent kinase inhibitors

Imidazopyrazines as cyclin dependent kinase inhibitors

US Patent 6919341 · Granted Jul 19, 2005

Estimated economic value: $160,529,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted aminothiazoles as inhibitors of nucleases2023
4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of le2022
Substituted propanamides as inhibitors of nucleases2022
Heterocycle-substituted tetracyclic compounds and methods of use thereof for the2020
Substituted triazolo bicyclic compounds as PDE2 inhibitors2019
Bicyclic heterocyclic compounds as PDE2 inhibitors2019
Compounds useful for treating disorders related to RET2019
Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors2019
6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors2018
Piperazine derivatives as HIV protease inhibitors2018
Pyrazolotriazines as inhibitors of nucleases2018
Furopyridines as inhibitors of protein kinases2018